It is also important to note that these are preliminary results and further testing is required prior to HAVcR-1 being used in this capacity, including greater sample numbers and trials to investigate whether serum HAVcR-1 levels can accurately diagnose prostate cancer as well as stage the disease. The gene discussed is HAVCR1; the disease is prostate carcinoma.